Full Text
EE551 Cost-Minimization of Faricimab Vs Aflibercept 8 Mg in Patients With Neovascular Age-Related Macular Degeneration (nAMD): Evaluating the Impact of Retreatment Criteria

Abstract

Authors

C Bührer M Bagijn A Fasci O Cox

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×